1. bookVolume 27 (2019): Issue 3 (July 2019)
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Antiphospholipid syndrome – a life threatening condition

Published Online: 30 Jul 2019
Page range: 333 - 337
Received: 13 Nov 2018
Accepted: 26 Feb 2019
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English

1. Bertolaccini ML, Amengual O, Andreoli L, Atsumi T, Chighizola CB, Forastiero R, et al. on behalf of the 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev. 2014. 13:917-30 DOI: 10.1016/j.autrev.2014.05.00110.1016/j.autrev.2014.05.001Open DOISearch in Google Scholar

2. An GD, Lim HH, Han JY. Laboratory Diagnosis of Antiphospholipid Syndrome. Clin Exp Thromb Hemost. 2017.3(1):2-7.10.14345/ceth.17002Search in Google Scholar

3. Uthman I, Khamashta M. Antiphospholipid syndrome and the kidneys. Semin Arthritis Rheum.2006. 1: 360–367 DOI: 10.1016/j.semarthrit.2006.01.00110.1016/j.semarthrit.2006.01.001Open DOISearch in Google Scholar

4. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002. 346(10):752–63. DOI: 10.1056/NEJMra00297410.1056/NEJMra002974Search in Google Scholar

5. Caraiola S, Jurcuț C, Dima A, Băicuș C, Băicuș A. Antiphosphatidylethanolamine Antibodies and Deep Vein Thrombosis in Lupus Patients with Antiphospholipid Syndrome. Rev Romana Med Lab. 2018;26(2):243-50 DOI: 10.2478/rrlm-2018-000910.2478/rrlm-2018-0009Open DOISearch in Google Scholar

6. Gavriş C, Anghel M, Rădoi M, Gheorghiţă E, Duca L, Pamfil G, et al. Risk of recurrent thrombosis related to antiphospholipid antibodies, soluble CD40L and P selectin serum levels in patients with antiphospholipid syndrome secondary to systemic lupus eritematosus. Rev Romana Med Lab. 2010;18(3):23-30Search in Google Scholar

7. Falanga A, Marchetti M, Russo L. The mechanisms of cancer-associated thrombosis. Thromb Res. 2015. 135(Suppl 1):S8-S11 DOI: 10.1016/S0049-3848(15)50432-510.1016/S0049-3848(15)50432-5Open DOISearch in Google Scholar

8. Passamonti F, Caramazza D, Mora B, Casalone R, Maffioli M. It is time to change thrombosis risk assessment for PV and ET? Best Pract Res Clin Haematol. 2014; 27(2):121-127 DOI: 10.1016/j.beha.2014.07.00510.1016/j.beha.2014.07.005Search in Google Scholar

9. Schulman S. How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy. BLOOD. 2017, 129(25):3285-3293.10.1182/blood-2017-03-742304Search in Google Scholar

10. Ahmed TS, Tewari P, Kaur J, Rizvi S, Nafsi T. Recurrence of Pulmonary Embolism While on Rivaroxaban: Treatment Failure. Chest Journal. 2016. 149(4):A05-0510.1016/j.chest.2016.02.527Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo